Document is current
Any future updates will be listed below
-
Authors
Dang, T.
Faje, A. T.
Meenaghan, E.
Bredella, M. A.
Bouxsein, M. L.
Klibanski, A.
Fazeli, P. K. https://orcid.org/0000-0003-1731-2927
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL 1TR002541)
National Center for Research Resources (UL1 RR025758)
National Center for Research Resources (1S10RR023405)
National Institutes of Health (R24 DK084970)
National Institutes of Health (P30 DK040561)
National Institutes of Health (K24DK109940)
National Institutes of Health (R01 HD099139)
- License Information
-
More Information
Article History
Received: 16 May 2022
Accepted: 5 August 2022
First Online: 23 August 2022
Declarations
:
: PKF is a consultant for Regeneron and Strongbridge Biopharma. Tran Dang, Alexander Faje, Erinne Meenaghan, Miriam Bredella, Mary Bouxsein and Anne Klibanski declare they have no conflict of interest.
